Journal of Bioprocessing & Biotechniques

ISSN: 2155-9821

Open Access

A Case of Advanced Pulmonary Adenocarcinoma Harboring HER-2 Amplification Treated with Afatinib


Yan Lu, Jiahui Lan, Ling Bi and Ling Xu*

HER-2 amplification is a rare mutation and potential target in the treatment of pulmonary adenocarcinoma (AC). Clinical efficacy of HER-2 targeted agent has been reported for AC with HER-2 exon 20 insertions; however it remains unknown for those with HER-2 amplification. Here we report a case of advanced AC harboring HER-2 amplification treated with afatinib, and objective response and symptom improvement were observed.

Share this article

Google Scholar citation report
Citations: 3351

Journal of Bioprocessing & Biotechniques received 3351 citations as per Google Scholar report

Journal of Bioprocessing & Biotechniques peer review process verified at publons

Indexed In

arrow_upward arrow_upward